BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / Common Stocks, par value $0,0001 per share
Symbol
BCAB on Nasdaq
Shares outstanding
58,548,563
Price per share
$0.57
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
13,349,032
Total reported value
$9,190,012
% of total 13F portfolios
0%
Share change
+165,424
Value change
+$218,759
Number of holders
43
Price from insider filings
$0.57
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIGHBRIDGE CAPITAL MANAGEMENT LLC 7.7% -22% $1,306,686 -$677,599 4,839,579 -34% Highbridge Capital Management, LLC 31 Mar 2025
ACORN BIOVENTURES, L.P. 8.3% $2,127,449 4,835,111 Anders Hove 15 May 2025
SHORT JAY M PHD 6.6% $1,043,724 3,865,646 Jay M. Short 31 Dec 2024
OPOKA INVESTMENT FUND Co 4.8% -22% $1,933,227 -$507,296 2,810,331 -21% OPOKA INVESTMENT FUND Co 09 Jul 2025
MILLENNIUM MANAGEMENT LLC 1.9% $295,814 1,095,606 Millennium Management LLC 31 Dec 2024

As of 30 Sep 2025, 43 institutional investors reported holding 13,349,032 shares of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB). This represents 23% of the company’s total 58,548,563 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) together control 23% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ACORN CAPITAL ADVISORS, LLC 8.3% 4,835,111 0% 1.7% $3,336,227
VANGUARD GROUP INC 3.3% 1,945,795 +9.1% 0% $1,338,707
TANG CAPITAL MANAGEMENT LLC 2.3% 1,374,076 0% 0.04% $945,227
ACADIAN ASSET MANAGEMENT LLC 1.6% 930,462 -38% 0% $638,000
RENAISSANCE TECHNOLOGIES LLC 1.4% 800,631 +6.2% 0% $550,754
DEUTSCHE BANK AG\ 0.9% 525,353 0% 0% $362,494
GEODE CAPITAL MANAGEMENT, LLC 0.85% 495,211 +0.6% 0% $340,731
BlackRock, Inc. 0.82% 480,933 0% 0% $330,834
MILLENNIUM MANAGEMENT LLC 0.58% 341,322 0% $234,795
CITADEL ADVISORS LLC 0.47% 274,036 0% $188,509
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.43% 252,583 +238% 0% $173,752
JANE STREET GROUP, LLC 0.33% 194,377 +1034% 0% $133,712
STATE STREET CORP 0.26% 151,377 0% 0% $104,132
NORTHERN TRUST CORP 0.17% 100,828 0% 0% $69,360
UBS Group AG 0.15% 86,743 +193% 0% $59,680
PVG ASSET MANAGEMENT CORP 0.11% 67,000 +3.1% 0.17% $46,089
Sheets Smith Investment Management 0.11% 67,000 0.03% $46,089
Magnus Financial Group LLC 0.08% 47,232 0% 0% $32,491
MAI Capital Management 0.08% 45,096 +1.9% 0% $31,022
HRT FINANCIAL LP 0.07% 43,356 +109% 0% $29,000
TWO SIGMA INVESTMENTS, LP 0.07% 40,716 -51% 0% $28,009
SIMPLEX TRADING, LLC 0.06% 36,156 +172% 0% $24,000
CITIGROUP INC 0.04% 26,132 0% $17,976
COLUMBIA ADVISORY PARTNERS LLC 0.04% 26,070 0% 0.01% $17,934
COMMONWEALTH EQUITY SERVICES, LLC 0.04% 25,300 0% 0% $17,000

Institutional Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 33,769 $19,171 -$15,460 $0.57 2
2025 Q3 13,349,032 $9,190,012 +$218,759 $0.69 43
2025 Q2 13,168,921 $5,214,805 -$178,443 $0.40 39
2025 Q1 13,676,589 $4,757,169 -$6,041,809 $0.35 40
2024 Q4 24,013,047 $14,192,370 -$3,754,504 $0.59 66
2024 Q3 17,292,318 $30,359,489 -$6,870,050 $1.76 62
2024 Q2 22,134,924 $30,398,249 -$9,185,046 $1.37 78
2024 Q1 24,865,828 $85,548,699 -$4,265,784 $3.44 83
2023 Q4 17,859 $43,933 $2.46 1
2023 Q3 29,405,065 $49,988,862 -$3,977,000 $1.70 79
2023 Q2 31,514,831 $94,544,563 -$2,354,415 $3.00 84
2023 Q1 32,818,125 $87,616,594 -$35,797,013 $2.68 78
2022 Q4 33,849,188 $279,246,047 +$75,601,654 $8.25 87
2022 Q3 22,962,108 $176,828,348 +$12,369,705 $7.70 65
2022 Q2 23,507,118 $66,946,060 -$8,827,590 $2.85 70
2022 Q1 25,528,610 $127,714,000 -$39,587,136 $5.00 90
2021 Q4 25,749,741 $505,464,807 +$1,201,394 $19.63 77
2021 Q3 25,335,459 $745,709,968 +$120,246,145 $29.44 81
2021 Q2 21,154,721 $896,537,925 +$89,235,042 $42.38 74
2021 Q1 19,002,884 $964,589,936 +$187,867,224 $50.84 62
2020 Q4 15,664,281 $530,219,000 +$530,209,257 $34.01 53